...
search icon
adma-img

ADMA Biologics Inc, Common Stock

ADMA

NMQ

$21.86

-$0.47

(-2.1%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$4.69B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
26.9036
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.62M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.53
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$6.49 L
$23.64 H
$21.86

About ADMA Biologics Inc, Common Stock

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameADMASectorS&P500
1-Week Return11.3%3.64%6.36%
1-Month Return8.11%-5.42%-5.32%
3-Month Return35.02%-6.89%-8.86%
6-Month Return38.27%-7.54%-5.61%
1-Year Return239.44%-1.81%8.61%
3-Year Return1009.64%2.1%27.58%
5-Year Return587.42%35.25%90.38%
10-Year Return153.3%88.1%160.03%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue42.22M80.94M154.08M258.21M426.45M[{"date":"2020-12-31","value":9.9,"profit":true},{"date":"2021-12-31","value":18.98,"profit":true},{"date":"2022-12-31","value":36.13,"profit":true},{"date":"2023-12-31","value":60.55,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue61.29M79.77M118.81M169.27M206.90M[{"date":"2020-12-31","value":29.62,"profit":true},{"date":"2021-12-31","value":38.55,"profit":true},{"date":"2022-12-31","value":57.43,"profit":true},{"date":"2023-12-31","value":81.81,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit(19.07M)1.17M35.27M88.94M219.55M[{"date":"2020-12-31","value":-8.69,"profit":false},{"date":"2021-12-31","value":0.53,"profit":true},{"date":"2022-12-31","value":16.06,"profit":true},{"date":"2023-12-31","value":40.51,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin(45.17%)1.45%22.89%34.44%51.48%[{"date":"2020-12-31","value":-87.74,"profit":false},{"date":"2021-12-31","value":2.82,"profit":true},{"date":"2022-12-31","value":44.46,"profit":true},{"date":"2023-12-31","value":66.9,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses45.84M59.55M74.63M67.31M80.57M[{"date":"2020-12-31","value":56.9,"profit":true},{"date":"2021-12-31","value":73.91,"profit":true},{"date":"2022-12-31","value":92.63,"profit":true},{"date":"2023-12-31","value":83.54,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(64.91M)(58.37M)(39.37M)21.63M138.98M[{"date":"2020-12-31","value":-46.71,"profit":false},{"date":"2021-12-31","value":-42,"profit":false},{"date":"2022-12-31","value":-28.32,"profit":false},{"date":"2023-12-31","value":15.56,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(22.53M)(26.54M)(45.98M)(73.41M)(25.10M)[{"date":"2020-12-31","value":-2253061100,"profit":false},{"date":"2021-12-31","value":-2653550500,"profit":false},{"date":"2022-12-31","value":-4598483200,"profit":false},{"date":"2023-12-31","value":-7341328700,"profit":false},{"date":"2024-12-31","value":-2510200000,"profit":false}]
Pre-Tax Income(75.75M)(71.65M)(65.90M)(28.24M)125.71M[{"date":"2020-12-31","value":-60.25,"profit":false},{"date":"2021-12-31","value":-56.99,"profit":false},{"date":"2022-12-31","value":-52.42,"profit":false},{"date":"2023-12-31","value":-22.46,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes11.86M12.81M19.28M8.16M(71.96M)[{"date":"2020-12-31","value":61.5,"profit":true},{"date":"2021-12-31","value":66.42,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":42.35,"profit":true},{"date":"2024-12-31","value":-373.24,"profit":false}]
Income After Taxes(87.61M)(84.45M)(85.18M)(36.40M)197.67M[{"date":"2020-12-31","value":-44.32,"profit":false},{"date":"2021-12-31","value":-42.72,"profit":false},{"date":"2022-12-31","value":-43.09,"profit":false},{"date":"2023-12-31","value":-18.42,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Continuous Operations(75.75M)(71.65M)(65.90M)(22.83M)197.67M[{"date":"2020-12-31","value":-38.32,"profit":false},{"date":"2021-12-31","value":-36.25,"profit":false},{"date":"2022-12-31","value":-33.34,"profit":false},{"date":"2023-12-31","value":-11.55,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(87.61M)(84.45M)(85.18M)(28.24M)197.67M[{"date":"2020-12-31","value":-44.32,"profit":false},{"date":"2021-12-31","value":-42.72,"profit":false},{"date":"2022-12-31","value":-43.09,"profit":false},{"date":"2023-12-31","value":-14.29,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
EPS (Diluted)(0.86)(0.52)(0.31)(0.13)0.50[{"date":"2020-12-31","value":-173.39,"profit":false},{"date":"2021-12-31","value":-104.84,"profit":false},{"date":"2022-12-31","value":-62.5,"profit":false},{"date":"2023-12-31","value":-26.21,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ADMA
Cash Ratio 1.86
Current Ratio 5.97
Quick Ratio 2.90

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ADMA
ROA (LTM) 21.24%
ROE (LTM) 81.64%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ADMA
Debt Ratio Lower is generally better. Negative is bad. 0.29
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.71

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ADMA
Trailing PE 26.99
Forward PE 28.99
P/S (TTM) 12.23
P/B 15.26
Price/FCF 110
EV/R 12.44
EV/Ebitda 35.93
PEG NM

FAQs

What is ADMA Biologics Inc share price today?

ADMA Biologics Inc (ADMA) share price today is $21.86

Can Indians buy ADMA Biologics Inc shares?

Yes, Indians can buy shares of ADMA Biologics Inc (ADMA) on Vested. To buy ADMA Biologics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ADMA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of ADMA Biologics Inc be purchased?

Yes, you can purchase fractional shares of ADMA Biologics Inc (ADMA) via the Vested app. You can start investing in ADMA Biologics Inc (ADMA) with a minimum investment of $1.

How to invest in ADMA Biologics Inc shares from India?

You can invest in shares of ADMA Biologics Inc (ADMA) via Vested in three simple steps:

  • Click on Sign Up or Invest in ADMA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in ADMA Biologics Inc shares
What is ADMA Biologics Inc 52-week high and low stock price?

The 52-week high price of ADMA Biologics Inc (ADMA) is $23.64. The 52-week low price of ADMA Biologics Inc (ADMA) is $6.49.

What is ADMA Biologics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of ADMA Biologics Inc (ADMA) is 26.9036

What is ADMA Biologics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of ADMA Biologics Inc (ADMA) is 15.26

What is the Market Cap of ADMA Biologics Inc?

The market capitalization of ADMA Biologics Inc (ADMA) is $4.69B

What is ADMA Biologics Inc’s stock symbol?

The stock symbol (or ticker) of ADMA Biologics Inc is ADMA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top